|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||65.16 - 65.87|
|52 Week Range||48.44 - 68.96|
|Beta (5Y Monthly)||0.41|
|PE Ratio (TTM)||26.57|
|Forward Dividend & Yield||1.57 (2.39%)|
|Ex-Dividend Date||Mar 27, 2020|
|1y Target Est||70.72|
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
During same 10-year period, Eisai and Abbott were worst performers in measure Continue reading...
Bagsværd, Denmark, 20 July 2020 – On 11 May 2020, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European.